155 related articles for article (PubMed ID: 22457233)
21. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.
Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
Tomography; 2016 Mar; 2(1):56-66. PubMed ID: 27200418
[TBL] [Abstract][Full Text] [Related]
22. Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models.
Inglese M; Ordidge KL; Honeyfield L; Barwick TD; Aboagye EO; Waldman AD; Grech-Sollars M
Neuroradiology; 2019 Dec; 61(12):1375-1386. PubMed ID: 31392385
[TBL] [Abstract][Full Text] [Related]
23. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic analysis of prostate cancer using independent component analysis.
Mehrabian H; Da Rosa M; Haider MA; Martel AL
Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
[TBL] [Abstract][Full Text] [Related]
25. Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer.
Vargas HA; Donati OF; Wibmer A; Goldman DA; Mulhall JP; Sala E; Hricak H
J Sex Med; 2014 Oct; 11(10):2581-8. PubMed ID: 24754351
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique.
Bonekamp D; Wolf MB; Edler C; Katayama S; Schlemmer HP; Herfarth K; Röthke M
Radiother Oncol; 2016 Aug; 120(2):313-9. PubMed ID: 27237059
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M
AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomy.
Parra NA; Orman A; Padgett K; Casillas V; Punnen S; Abramowitz M; Pollack A; Stoyanova R
Strahlenther Onkol; 2017 Jan; 193(1):13-21. PubMed ID: 27761612
[TBL] [Abstract][Full Text] [Related]
30. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results.
Akin O; Gultekin DH; Vargas HA; Zheng J; Moskowitz C; Pei X; Sperling D; Schwartz LH; Hricak H; Zelefsky MJ
Eur Radiol; 2011 Sep; 21(9):1970-8. PubMed ID: 21533634
[TBL] [Abstract][Full Text] [Related]
31. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI.
Noworolski SM; Henry RG; Vigneron DB; Kurhanewicz J
Magn Reson Med; 2005 Feb; 53(2):249-55. PubMed ID: 15678552
[TBL] [Abstract][Full Text] [Related]
32. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI.
Kiessling F; Lichy M; Grobholz R; Heilmann M; Farhan N; Michel MS; Trojan L; Ederle J; Abel U; Kauczor HU; Semmler W; Delorme S
Eur Radiol; 2004 Oct; 14(10):1793-801. PubMed ID: 15232714
[TBL] [Abstract][Full Text] [Related]
33. Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage.
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Contrast Media Mol Imaging; 2018; 2018():3181258. PubMed ID: 30327584
[TBL] [Abstract][Full Text] [Related]
34. Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard Tofts model in the diagnosis of prostate cancer.
Zhou X; Fan X; Chatterjee A; Yousuf A; Antic T; Oto A; Karczmar GS
Res Sq; 2023 Feb; ():. PubMed ID: 36798227
[TBL] [Abstract][Full Text] [Related]
35. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
36. High temporal resolution 3D gadolinium-enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: preliminary observations.
Chandarana H; Amarosa A; Huang WC; Kang SK; Taneja S; Melamed J; Kim S
J Magn Reson Imaging; 2013 Oct; 38(4):802-8. PubMed ID: 23389833
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the effect of haematocrit-dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast-enhanced MRI.
Just N; Koh DM; D'Arcy J; Collins DJ; Leach MO
NMR Biomed; 2011 Aug; 24(7):902-15. PubMed ID: 21290457
[TBL] [Abstract][Full Text] [Related]
38. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
[TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
